XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Payments: (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]            
Share-based Payment Arrangement, Expense $ 1,450 $ 720   $ 1,070 $ 1,190  
Allocated share-based compensation expense, effect on net income attributable to parent 940 $ 460   $ 670 $ 860  
Weighted average remaining contractual life of options exercisable   2 years 11 months 4 days        
Weighted average remaining contractual life of options outstanding, options exercisable   2 years 2 months 23 days        
Aggregate intrinsic value of options outstanding 11,500 $ 11,500        
Aggregate intrinsic value of exercisable options 8,300 8,300        
Unrecognized compensation cost related to stock options $ 3,700 $ 3,700        
Interparfums SA Subsidiary [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Adjusted for stock splits (in Shares) 173,603 173,603        
Revaluation resulted in reduction of cost, description   The original cost of the grant was approximately $4.4 million, and the modification resulted in a revised cost of approximately $4.7 million.        
Original cost of grant   $ 4,400        
Modification resulted revised cost   4,700        
Interparfums SA Subsidiary [Member] | Employees [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Adjusted for stock splits (in Shares)           26,600
Interparfums SA Subsidiary [Member] | Officers And Managers [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Adjusted for stock splits (in Shares)           133,000
Equity Option [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Fair value of shares vested   $ 90 $ 80      
Equity Option [Member] | Minimum [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Share-based compensation arrangement by share-based payment award, award vesting period   4 years        
Equity Option [Member] | Maximum [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Share-based compensation arrangement by share-based payment award, award vesting period   5 years